Bristol Myers Squibb today announced positive topline results from SCOUT-HCM, a Phase 3 trial evaluating Camzyos (mavacamten) ...
The U.S. Food and Drug Administration has approved Myqorzo (aficamten) for the treatment of adults with symptomatic ...
Pharmaceutical Technology on MSN
Cytokinetics receives FDA approval for MYQORZO tablets for oHCM
Cytokinetics has announced that the US Food and Drug Administration (FDA) has approved MYQORZO (aficamten) tablets in 5mg, 10mg, 15mg, and 20mg doses for adults with symptomatic obstructive ...
This study demonstrates that fast raster-scan optoacoustic mesoscopy (fRSOM) enables non-invasive, detailed visualization of ...
Review clinical classifications, diagnostic procedures, and management strategies for cardiomyopathy and heart failure in this comprehensive overview.
“Patients with pulmonary edema generally describe breathlessness. Sometimes they feel like they are suffocating or breathing ...
Background Ebstein’s anomaly (EA) exhibits significant anatomical and clinical heterogeneity, warranting a systematic ...
Andrea Dossena previously admitted that the failure of his Liverpool career lies solely at his feet. The former footballer signed for the Premier League giants in 2008 in a £7million deal. Joining as ...
Failure can be hard to handle. A big swing and a miss — whether it’s in your personal or professional life — can distort your vision of yourself, torpedoing confidence and convincing you that you’re ...
Follow ZDNET: Add us as a preferred source on Google. Inside our homes, though, Amazon Alexa has become the most popular virtual assistant in the US and around the world, as a widely adopted virtual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback